Patents by Inventor Matthew Alles

Matthew Alles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260061129
    Abstract: Exemplary embodiments may enable a user to schedule medicament bolus deliveries, such as insulin boluses, for future dates and times. The exemplary embodiments may provide the ability to delay a scheduled medicament bolus delivery by short periods of time. The user may reschedule a scheduled medicament bolus delivery by entering a new date and/or time for the medicament bolus delivery. Still further, a user may cancel a scheduled medicament bolus delivery. In addition, exemplary embodiments may enable multiple medicament bolus deliveries to be viewed and managed.
    Type: Application
    Filed: November 10, 2025
    Publication date: March 5, 2026
    Inventors: Matthew ALLES, Daniel MURRAY, Joon Bok LEE, Jason O’CONNOR
  • Patent number: 12491316
    Abstract: Exemplary embodiments may enable a user to schedule medicament bolus deliveries, such as insulin boluses, for future dates and times. The exemplary embodiments may provide the ability to delay a scheduled medicament bolus delivery by short periods of time. The user may reschedule a scheduled medicament bolus delivery by entering a new date and/or time for the medicament bolus delivery. Still further, a user may cancel a scheduled medicament bolus delivery. In addition, exemplary embodiments may enable multiple medicament bolus deliveries to be viewed and managed.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: December 9, 2025
    Assignee: INSULET CORPORATION
    Inventors: Matthew Alles, Daniel Murray, Joon Bok Lee, Jason O′Connor
  • Publication number: 20250288740
    Abstract: A system and device for establishing a customized mode of a medicament delivery algorithm. The device may include a processor configured to receive an indication to establish a custom mode. The device implements an initial learning phase. A processor executing the initial learning phase receives and evaluates sensor data for a duration of time. A sensor operable to make analyte measurements may provide analyte measurement values. Based on a result of the initial learning phase, the device sets medicament delivery algorithm parameters for the custom mode, thereby establishing the custom mode for operation of a wearable automated medicament delivery system.
    Type: Application
    Filed: January 23, 2025
    Publication date: September 18, 2025
    Inventors: Joon Bok LEE, Yibin ZHENG, Matthew ALLES, Jason O’CONNOR
  • Publication number: 20250246285
    Abstract: Techniques, systems and devices for glycemic control are presented. An apparatus may include a display device and a processor in electronic communication with the display device. The apparatus includes a memory communicatively connected to the processor. The memory includes instructions configuring the processor to generate a user interface through the display device and receive user input through the user interface. The processor is configured to implement an activity mode of a plurality of activity modes of a wearable medical device based on the user input. The activity mode is indicative of temporary conditions affecting blood glucose levels of the user. The processor is configured to receive biological data from a user through a biological sensor in communication with the processor and calculate an amount of medication to deliver to a user based on the biological data and the implemented activity mode.
    Type: Application
    Filed: January 23, 2025
    Publication date: July 31, 2025
    Inventors: Matthew ALLES, Joon Bok LEE, Yibin ZHENG, Jason O'CONNOR
  • Publication number: 20250065039
    Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.
    Type: Application
    Filed: September 13, 2024
    Publication date: February 27, 2025
    Inventors: Jason O'CONNOR, Matthew ALLES, Robert SANZONE, Craig BRODEUR, Joseph MELO, Christopher WILLIAMS, Noel SCHAEFFER
  • Patent number: 12097352
    Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: September 24, 2024
    Assignee: INSULET CORPORATION
    Inventors: Jason O'Connor, Matthew Alles, Robert Sanzone, Craig Brodeur, Joseph Melo, Christopher Williams, Noel Schaeffer
  • Publication number: 20240148971
    Abstract: Exemplary embodiments may provide an on-body medicament delivery system that provides basal delivery of a medicament to a type 2 diabetes patient and that automatically performs medicament titration for the patient. The medicament delivery system performs medicament titration based on glucose level readings for the patient. These glucose levels may be provided wirelessly from a glucose sensor, such as a continuous glucose monitor, or may be entered manually by the patient into a management device, such as a smartphone running an application that provides a user interface for the patient to enter the glucose level readings. The medicament delivery system adjusts the basal medicament delivery rate/dose based on the glucose level readings for the patient. The adjustments may be performed by a programmatic mechanism, such as by computer programming instructions executing on a processor.
    Type: Application
    Filed: November 3, 2023
    Publication date: May 9, 2024
    Inventors: Matthew ALLES, Yibin ZHENG, Joon Bok LEE, James CAUSEY, Jason O'CONNOR
  • Publication number: 20230011699
    Abstract: Provided are techniques, devices and systems that include monitoring a trend of blood glucose measurement values over a series of measurement cycles. A processor may identify a potential excursion outside a range of a target blood glucose measurement value setting of a user based on the monitored trend. In response to the identified potential excursion, an alert may be generated to the user to consume rescue carbohydrates. In addition, the disclosed techniques may include a processor that assesses the factors related to a potential impending hypoglycemic event for a user. Based on a result of the assessment of the factors, the processor may determine whether the user is approaching the potential impending hypoglycemic event for the user. In response to a determination that the user is approaching the potential impending hypoglycemic event for the user, a number of rescue carbohydrates to suggest for consumption by the user may be determined.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 12, 2023
    Inventors: Joon Bok LEE, Matthew ALLES, Yibin ZHENG, Jason O'CONNOR
  • Publication number: 20220193337
    Abstract: The exemplary embodiments may provide a smartwatch or a vehicle infotainment system with management and data inspection capabilities for a medicament delivery system. A user may view medicament delivery history and analyte level history via the smartwatch or auto mobile infotainment system. In addition, a user may calculate a medicament dosage and prompt delivery of the medicament bolus dosage via the smartwatch or vehicle infotainment system. Notifications also may be delivered to the user via the smartwatch and vehicle infotainment system.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 23, 2022
    Inventors: Matthew ALLES, Joon Bok LEE
  • Publication number: 20220199215
    Abstract: Exemplary embodiments may enable a user to schedule medicament bolus deliveries, such as insulin boluses, for future dates and times. The exemplary embodiments may provide the ability to delay a scheduled medicament bolus delivery by short periods of time. The user may reschedule a scheduled medicament bolus delivery by entering a new date and/or time for the medicament bolus delivery. Still further, a user may cancel a scheduled medicament bolus delivery. In addition, exemplary embodiments may enable multiple medicament bolus deliveries to be viewed and managed.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 23, 2022
    Inventors: Matthew ALLES, Daniel MURRAY, Joon Bok LEE, Jason O'CONNOR
  • Publication number: 20220062536
    Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.
    Type: Application
    Filed: August 26, 2021
    Publication date: March 3, 2022
    Inventors: Jason O'CONNOR, Matthew ALLES, Robert SANZONE, Craig BRODEUR, Joseph MELO, Christopher WILLIAMS, Noel SCHAEFFER
  • Publication number: 20050047044
    Abstract: A power conversion system and methods of power conversion and construction of such a system are disclosed, where the system includes at least two pairs of input and output bus bars, and two pairs of switching devices, with the switching devices of each respective pair coupled in parallel in between a respective pair of the bus bars. When one of the switching devices of each pair is closed, the bus bars of the respective pair of bus bars are short-circuited to one another, thus bypassing the other of the switching devices of each pair. The other of the switching devices of each pair is attached to at least one intermediate portion, which in turn is attached to a mass. Substantially all the heat generated by the other of the switching devices of each pair is communicated to the mass, which has a heat capacity capable of receiving that heat.
    Type: Application
    Filed: August 29, 2003
    Publication date: March 3, 2005
    Inventors: Paul Nolden, Steven McLaughlin, Matthew Alles
  • Patent number: D889193
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: July 7, 2020
    Inventor: Matthew Alles
  • Patent number: D954492
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: June 14, 2022
    Assignee: Chason LLC
    Inventor: Matthew Alles
  • Patent number: D1001609
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: October 17, 2023
    Inventor: Matthew Alles
  • Patent number: D1024314
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: April 23, 2024
    Assignee: INSULET CORPORATION
    Inventors: Derek Rund, Josh Haldeman, Mary Friedl, Michael Palmisano, Tony Guard, Jeffrey Barnes, Ayden Henson, David Seward, Steven Cardinali, Matthew Alles, Robert Sanzone
  • Patent number: D1082480
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: July 8, 2025
    Inventor: Matthew Alles
  • Patent number: D1115022
    Type: Grant
    Filed: May 15, 2025
    Date of Patent: February 24, 2026
    Assignee: INSULET CORPORATION
    Inventors: Derek Rund, Josh Haldeman, Mary Friedl, Michael Palmisano, Tony Guard, Jeffrey Barnes, Ayden Henson, David Seward, Steven Cardinali, Matthew Alles, Robert Sanzone